0001104659-07-060717 Sample Contracts

PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENT

Change of Control Agreement • August 9th, 2007 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Change of Control Agreement
• Filed
  August 9th, 2007
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Change of Control Agreement (VP) (this “Agreement”), dated as of May 7, 2007, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13, the “Company”), and Ronald A. Martell (the “Executive”).

PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT

Key Executive Severance Agreement • August 9th, 2007 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Key Executive Severance Agreement
• Filed
  August 9th, 2007
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Key Executive Severance Agreement (VP) (this “Agreement”), dated as of May 7, 2007, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Ronald A. Martell (the “Executive”).

PONIARD PHARMACEUTICALS, INC. NONQUALIFIED STOCK OPTION AGREEMENT UNDER THE RESTATED 2004 INCENTIVE COMPENSATION PLAN (Nonemployee Directors)

Nonqualified Stock Option Agreement • August 9th, 2007 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Nonqualified Stock Option Agreement
• Filed
  August 9th, 2007
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

THIS AGREEMENT is made between Poniard Pharmaceuticals, Inc. (“Poniard”) and «Name». Capitalized terms not explicitly defined in this Agreement but defined in the Poniard Pharmaceuticals, Inc. 2004 Incentive Compensation Plan (the “Plan”) shall have the same definitions as in the Plan.